Abstract: An arc wire spraying method includes conveying at least two wires out of respective lance nozzles of a wire conveying device by means of the wire conveying device, applying current to the two wires to form an arc for melting the ends of the two wires, and applying airflow to the arc in the direction transverse to the longitudinal direction of the wire conveying device by means of an airflow applying device so as to spray the melted wire material toward a surface to be sprayed. The airflow applying device rotationally applies the airflow around the longitudinal direction of the wire conveying device. Parameters for spraying are variably adjusted along the rotating direction of the airflow applying device. The airflow is rotationally applied at a varying rotating speed.

Abstract: An arc wire spraying method includes conveying at least two wires out of respective lance nozzles of a wire conveying device by means of the wire conveying device, applying current to the two wires to form an arc for melting the ends of the two wires, and applying airflow to the arc in the direction transverse to the longitudinal direction of the wire conveying device by means of an airflow applying device so as to spray the melted wire material toward a surface to be sprayed. The airflow applying device rotationally applies the airflow around the longitudinal direction of the wire conveying device. Parameters for spraying are variably adjusted along the rotating direction of the airflow applying device. The airflow is rotationally applied at a varying rotating speed.

Abstract: It is provided a solid pharmaceutical composition comprising sofosbuvir, one or more pharmaceutically acceptable excipients and optionally at least one pharmaceutically acceptable matrix compound, wherein at least 99 weight-% of the sofosbuvir comprised in the solid pharmaceutically composition are present in amorphous form. Sofosbuvir amorphous form is stable in the solid pharmaceutical composition.

Abstract: A tablet comprising a polymorphic form of crystalline sofosbuvir having a moisture stability of at least 95% in an amount of at least 40 weight-%.

Abstract: The present invention relates to an oral solid dosage form, in particular a tablet, comprising sorafenib tosylate polymorphic form III.

Abstract: The present invention relates to an oral solid dosage form, in particular a tablet, comprising sorafenib tosylate polymorphic form III.

Abstract: Pellets of granulated particles comprising at least one pharmaceutically active compound, which pellets are characterised in that a bad taste of a pharmaceutically active compound when taken by patients is reduced or eliminated, said pellets comprise a pharmaceutically active compound and further comprise an organic carboxylic acid and/or a surfactant and/or a hydrocolloid and said pellets are coated with an enteric film-forming composition comprising an enteric film-forming component and pharmaceutical compositions comprising such pellets.

Abstract: The present invention relates to a pharmaceutical composition for oral administration suitable for the preparation of a ready-to-use suspension comprising coated particles comprising an active substance having an unpleasant and/or bitter taste, such as clarithromycin, and a suspension base comprising an osmotically active substance capable of providing a high osmolality to the admixture of the suspension base with an aqueous suspending medium in the ready-to-use suspension. Said ready-to-use suspension maintains its palatability over a prolonged period of time by those defined osmotic conditions.

Abstract: A pharmaceutical composition comprising an active ingredient and clavulanate wherein the clavulanate is in the form of granulated and hydrophobised particles; and intermediates in its preparation, e.g. clavulanate in granulated and/or hydrophobised form.

Abstract: Pellets of granulated particles comprising at least one pharmaceutically active compound, which pellets are characterised in that a bad taste of a pharmaceutically active compound when taken by patients is reduced or eliminated, said pellets comprise a pharmaceutically active compound and further comprise an organic carboxylic acid and/or a surfactant and/or a hydrocolloid and said pellets are coated with an enteric film-forming composition comprising an enteric film-forming component and pharmaceutical compositions comprising such pellets.

Abstract: An oral suspension comprising (a) an antibiotic composition which comprises coated micropellets and optionally one or more excipients, (b) additional excipients, and (c) a solvent, wherein said coated micropellets comprise (i) a core comprising at least one antibiotic; (ii) an inner coating comprising at least one cellulose polymer which is not an enteric coating polymer; and (iii) an outer coating comprising at least one enteric coating polymer, wherein said coated micropellets have a mean particle size of about 100 ?m to about 650 ?m. The oral suspension of the invention is characterized by a lack of bitter taste.

Abstract: The preparation of an improved galenic delivery form of valnemulin, which is notable for its good tolerance and stability in storage, is described. The new delivery form in question is a non-aqueous or oily injection formulation, which is obtainable by means of in-situ preparation and subsequent stabilisation of the free, relatively unstable base of the active ingredient. A further aspect of the present invention concerns the usage of such an injection formulation in a method of treating infectious diseases in productive livestock or domestic animals.

Abstract: The preparation of an improved galenic delivery form of valnemulin, which is notable for its good tolerance and stability in storage, is described. The new delivery form in question is a non-aqueous or oily injection formulation, which is obtainable by means of in-situ preparation and subsequent stabilisation of the free, relatively unstable base of the active ingredient. A further aspect of the present invention concerns the usage of such an injection formulation in a method of treating infectious diseases in productive livestock or domestic animals.

Abstract: A data transfer device for unidirectional serial data transfer from a transmitting device to a receiving device, in particular from a microcontroller to an output stage IC of a motor vehicle control unit. The data transfer device includes a P/S converter provided in the transmitting device for converting a parallel data stream made available in the transmitting device into a serial data stream with transfer frames of a predefined format and for transmitting the serial data stream to the receiving device over a data transfer channel. The data transfer device also includes an S/P converter provided in the receiving device for converting the transmitted serial data stream back into a parallel data stream, and a clock signal generating device for generating a clock signal and for sending the clock signal to the P/S converter and the S/P converter to perform the conversion operations continuously and in-phase.

Abstract: Method for checking a predetermined monitoring area, wherein at least one distance sensor provided in particular in the edge region of the monitored area, which transmits a scanning beam which sweeps over the monitored area in a predetermined scanning movement and thereby changes its direction, which receives the scanning beam which is reflected at boundaries of the monitored area and/or at objects located in the monitored area, and which determines a distance signal representative of the distance of the point of reflection of the scanning beam from the distance sensor and also a direction signal representing the direction of the scanning beam. The distance signals and the direction signals found during the scanning movement define a distance contour function, and an evaluation unit connected to the distance sensor compares the distance contour function which has been found with at least one stored reference contour function representing an expected object contour.

Abstract: The invention relates to an optical detection device for determining the position of an indicator medium on or in front of a projection surface with an optical monitoring field arranged directly in front of or slightly spaced from the presentation surface parallel to the latter, wherein either at least one scanner is provided which transmits light beams in the plane of the monitoring field, which scans the monitoring field and delivers angle and distance measurements related to the respective position of the indicator medium in the monitoring field, or wherein, starting from two different positions, range and/or angle measurement devices are provided which transmit light beams in the plane of the monitoring field, and wherein the angular range scanned by each of the two range and/or angle distance measuring devices respectively embraces the whole monitoring field, and wherein the respective position of the indicator medium in the monitoring field can be computed from the range and angular values delivered by

Abstract: The analyzer circuit includes a first oscillator producing an output signal having a first frequency depending on an inductance of an inductive position sensor having two oscillator coils positioned near a movable part; a switching device in the first oscillator for alternatingly connecting one of the two coils and simultaneously disconnecting the other according to a state of the switching device; a frequency divider for converting the output signal at the first frequency to another output signal at another frequency; a counter for counting a pulse signal under control of the other output signal of the frequency divider; a second oscillator connected to the counter and providing input pulses at a fixed frequency to the counter, which counts the input pulses under control of the other output signal of the frequency divider; a start synchronizing circuit for starting and synchronizing the divider and the counter; a flip-flop connected to the frequency divider and to the switching device to switch the state of